Bacillus amyloliquefaciens NB, a glutamate-independent poly-γ-glutamic acid (γ-PGA)-producing strain, can directly utilize inulin-containing sustainable materials. However, low γ-PGA yield and lack of efficient genetic engineering approaches have hindered the industrial use of this strain. Here, we used the CRISPR-Cas9n technique to engineer B. amyloliquefaciens to enhance γ-PGA production. We engineered three modules involved in inulin hydrolysis, reducing sugars metabolism, and γ-PGA synthesis in B. amyloliquefaciens. Specifically, overexpresed the native inulin hydrolase CscA and two expressionoptimized levanase and endoinulinase, overexpressed of key genes related to reducing sugar metabolism to increased ATP production, and removed polysaccharide operon epsA-O and γ-PGA hydrolase cwlO. Finally, the highest production of γ-PGA (32.14 ± 0.38 g/L) was obtained in a 7.5 L fed-batch fermenter. Thus, we successfully constructed an ideal candidate strain for efficient γ-PGA production from inulin, which provides an important research basis for the development of more biobased products.